The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
The treatment reprograms T cells to hunt down a patient's cancer. The approach could speed treatment and cut costs, but needs more study. With just a single injection, a new treatment transforms ...
VANCOUVER, BC, Dec. 4, 2025 /PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results